Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Resources>White Papers>This White Paper
  White Papers
Scientific News
Molecular Mechanism For Generating Specific Antibody Responses Discovered
Study could spur more ways to treat autoimmune disease, develop accurate vaccines.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Improving Flu Vaccine Effectiveness
NIH study finds factors that may influence influenza vaccine effectiveness.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Scroll Up
Scroll Down

Product Lifecycle Management: Maximizing profit and leveraging innovation
Bookmark and Share

Vetter Pharma International GmbH

The cost of developing a new drug is continuously rising. Many other factors, such as stricter regulations and stronger global competition, are also creating major challenges. If a pharmaceutical company intends to increase its market share and return on investment, it must consider how to maintain a drug‘s profitability even after its patents have expired. Product Lifecycle Management (PLM) is a viable option for extending profitability, and there are several methods for approaching PLM effectively. What is crucial, however, is to plan for it early on, even, if possible, before the drug actually enters the market.

The key to successful Product Lifecycle Management is to create and evolve a proactive strategy for the product throughout its entire useful life, from its launch through to its long-term growth and acceptance in the market.

Further Information

Related Content

Creation of a New 70 Million Euro Vetter Production Building
Company has announced that the new construction at a ground breaking ceremony represents an important component of a previously announced investment strategy.
Wednesday, March 23, 2016
Vetter Development Service Chicago Completes Recent On-Site Expansion Activities
Continued demand and increased customer product transfers are generating a positive business outlook for the company’s early-stage development facility.
Thursday, June 11, 2015
Vetter Continues to Expand Capacity
Structural work completed on Vetter’s new multi-functional building for its Development Service and information technology (IT).
Friday, January 30, 2015
Vetter Adds Flexible Serialization Service to its Portfolio
A new service allowing for the explicit identification of drug packaging.
Thursday, December 04, 2014
Vetter Announces Opening of Office to Support Growing Asian Healthcare Market
New Asia Pacific office will support customer relations and the development of new business.
Friday, November 21, 2014
Vetter to Construct New Filling Lines to Expand Capacity
Responding to customer demand and company growth.
Thursday, October 10, 2013
Vetter’s New Commercial Filling Line Ready for cGMP Filling
Novel, high-tech line fully validated; first customer project underway.
Monday, April 08, 2013
Vetter’s Newest Facility Successfully Completes FDA Inspection
Center for visual inspection and logistics sets high safety and control standards.
Thursday, March 28, 2013
Vetter Offers Answers for the Future at the Pharma Congress 2013
Experts from the CDMO to discuss the challenges and solutions facing the industry.
Tuesday, February 19, 2013
Vetter Receives Top Prize at the European Outsourcing Awards Ceremony
CDMO clinches an industry Oscar for its innovative high-speed filling line.
Friday, October 12, 2012
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!